BioSpace News Archive

Seres Therapeutics, Inc., a leading microbiome therapeutics platform company developing a novel class of multifunctional bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease, announced the pricing of an underwritten public offering of 10,500,000 shares of its common stock, at a public offering price of $21.50 per share, before underwriting discounts and commissions.

Schrödinger, Inc., whose differentiated, physics-based software platform enables discovery of high-quality, novel molecules for drug development and materials applications, announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock at a public offering price of $66.00 per share.

Sapience Therapeutics, Inc., a biotechnology company focused on the discovery and development of peptide therapeutics to address difficult-to-treat oncology indications, today announced dose administration for the first patient in a Phase 1/2, open-label, dose escalation and expansion study of single agent ST101,

Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced financial results for the second quarter 2020.

Cytovia Therapeutics, Inc (Cytovia), an emerging biopharmaceutical company developing CAR NK cell therapy and NK engager antibodies for cancer, announced today that it has licensed from ProteoNic BV its 2G UNic™ technology for boosting recombinant protein production, allowing for cost-effective manufacturing at large scale

Mylan N.V. (NASDAQ: MYL) and Sesame Workshop, the non-profit educational organization behind Sesame Street, today announced a new effort to help children and families cope with the ongoing transitions and uncertainty stemming from the COVID-19 pandemic.

Connecticut-based medical device innovator Lumendi, LLC has announced a change in the company’s Mission & Vision statements to better communicate the intended path of its innovative DiLumenTM Endolumenal Interventional Platform to transform the GI landscape from surgical intervention to endolumenal.

GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), the global leader in neonatal and pediatric genetic testing, announced the entrance into an agreement with Pediatrix Medical Group (“Pediatrix”), the nation’s leading provider of maternal-fetal, and pediatric medical and surgical sub

Landmark Cell Publication Reveals Novel Spatial Biology Discoveries Enabled by the CODEX® Platform New peer-reviewed paper outlines novel organizing principles and spatial interactions between “neighborhoods” of cells in the tumor microenvironment of colorectal cancer. MENLO PARK, Calif.--( BUSINESS WIRE )-- Akoya Biosciences, Inc., The Spatial Biology Company™, today announced the application of the CODEX® platform to a recent Cell publication ti

Ontera, Inc., the leader in silicon-based nanopore sensing and diagnostics, is taking another step toward realizing its mission of providing better biological information for a healthier planet; this time, by spinning out a new company, Nooma Bio, Inc. (Nooma).